Search clinical trials for: TNB-383B

Total 1362 results

AbbVie

Recruiting

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving ABBV-383 as an Intravenous (IV) Infusion

Immunoglobulin Light Chain (AL) Amyloidosis

Japan
TeneoOne Inc.

No longer available

Expanded Access for TNB-383B in a Subject With Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

United States
TeneoOne Inc.
AbbVie

Active, not recruiting

A Study of TNB-383B in Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States, Germany
University of Thessaly

Completed

Metabolic Cost of Medicine Ball Training (MΒT-UTH)

Body Composition | Physical Fitness | Energy Expenditure | Resting Metabolic Rate

Greece
AbbVie

Not yet recruiting

Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma
AbbVie

Active, not recruiting

A Study to Assess Adverse Events and Change in Disease State of Intravenously (IV) Infused ABBV-383 of Adult Participants With Relapsed or Refractory Multiple Myeloma in Japan

Relapsed/Refractory Multiple Myeloma

Japan
Medtronic Cardiac Rhythm and Heart Failure

Terminated

Optimize RV Selective Site Pacing Clinical Trial

Cardiac Pacemaker, Artificial | Cardiac Pacing, Artificial

Canada, United States, Israel, Italy, Qatar, China
TeneoOne Inc.

Recruiting

A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

Israel, United States, Canada, Spain, France, Denmark, United Kingdom
David Haines, MD

Terminated

Left Bundle Area Versus Selective His Bundle Pacing (LEFTBASH)

Bradycardia | Atrioventricular Block | Sinus Node Dysfunction

United States
TeneoFour Inc.
Novotech (Australia) Pty Limited

Completed

A Single and Multiple Dosing Study Targeting Biparatopic Antibody CD38 in Healthy Volunteers

Healthy Volunteer

Australia
Chong Kun Dang Pharmaceutical

Completed

Evaluate the Pharmacokinetics and Safety Between the Treatment of CKD-383 and Treatment of CKD-501, D745, D150, and D029

Type 2 Diabetes

Korea, Republic of
Achaogen, Inc.

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interaction Potential of ACHN-383 and ACHN-789

Healthy Volunteers

Australia
Medtronic Cardiac Rhythm and Heart Failure

Completed

Optimize RV Follow-up Selective Site Pacing Clinical Trial (ORVFUP)

Cardiac Pacing | Right Ventricular Pacing | Left Ventricular Ejection Fraction

United States, Israel, Italy
Chong Kun Dang Pharmaceutical

Completed

Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-383 and the Co-administration of CKD-501, D744, and D150

Type 2 Diabetes

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383.

Type2 Diabetes Mellitus

Korea, Republic of
AstraZeneca

Recruiting

A Study of AZD0486 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Follicular Lymphoma | Diffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | B-cell Non Hodgkin Lymphoma

Korea, Republic of, United States, Japan, Australia, Taiwan
University Hospital of Patras

Completed

Left Bundle Branch Pacing Versus Conventional Pacing in Atrioventricular Block

Atrioventricular Nodal Disease

Greece
Maastricht University Medical Center
Medtronic Bakken Research Center

Completed

Left Ventricular Septum Pacing in Patients by Transvenous Approach Through the Inter-ventricular Septum

Heart Failure | Sick Sinus Syndrome | Left Ventricular Dysfunction | Cardiac Conduction Defect

Netherlands
Alkermes, Inc.

Completed

A Phase 1 Safety Study in Adults With Schizophrenia

Schizophrenia

United States
Purdue University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Effects of Food Form on Cephalic Phase Responses

Overweight | Obese

United States
McGill University Health Centre/Research Institute...
Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation...

Recruiting

Conduction System Pacing With Left Bundle Branch Pacing as Compared to Standard Right Ventricular Pacing

Heart Block | Pacemaker DDD

Canada
Alkermes, Inc.

Completed

Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831

Schizophrenia | Schizophreniform Disorder | Bipolar I Disorder

United States, Bulgaria, Russian Federation, Ukraine, Austria, Ireland, Israel, Italy, Korea, Republic of, Poland, United Kingdom, Serbia, Puerto Rico
Alkermes, Inc.

Completed

A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia

Schizophrenia

United States, Puerto Rico
Presidio Pharmaceuticals, Inc.

Completed

A Phase 1a/1b Study of PPI-383 in Healthy Adults and Hepatitis C Patients

Hepatitis C, Chronic

United Kingdom, Mauritius
Alkermes, Inc.

Completed

A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia

Schizophrenia

United States, Bulgaria, Ukraine, Serbia
Dong-A ST Co., Ltd.

Completed

A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab.

Acute Gastritis | Chronic Gastritis

Korea, Republic of
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...

Completed

Vagal Nerve Stimulation and Glucose Metabolism

Obesity | Type 2 Diabetes | Gastric Emptying

United States
Alkermes, Inc.

Enrolling by invitation

Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects

Schizophrenia | Bipolar I Disorder

United States, Argentina, Brazil, Colombia, Mexico
Alkermes, Inc.

Completed

Phase 1 Study of OLZ/SAM in Pediatric Subjects With Bipolar I Disorder

Bipolar I Disorder

United States
Chong Kun Dang Pharmaceutical

Unknown

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-333 Low Dose in Healthy Volunteers

Cardiovascular Disease

Korea, Republic of
Chong Kun Dang Pharmaceutical

Unknown

Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers

Cardiovascular Disease

Korea, Republic of
Transwell Biotech Co., Ltd.

Completed

TWB-103 for Treating Lower Limb Ulcers on Patients With DM

Diabetic Foot Ulcer

Taiwan
Biocad

Recruiting

Study of the Safety and Efficacy of an Adeno-Associated Viral Vector Carrying the SMN Gene After a Single Intravenous Administration of Escalating Doses in Children With Spinal Muscular Atrophy (BLUEBELL) (BLUEBELL)

Spinal Muscular Atrophy (SMA)

Belarus, Russian Federation
Chong Kun Dang Pharmaceutical

Unknown

A Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of CKD-333 or Co-administration of CKD-333 and D085 in Healthy Volunteers (CKD-333)

Cardiovascular Diseases
TenNor Therapeutics (Suzhou) Limited

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effect of TNP-2198 Capsules After Single Oral Dose in Healthy Participants

Helicobacter Pylori Infection

China
Amanda Dandanell Juul

Recruiting

Navigation Endobronchial Ultrasound (NEBULA)

Lung Cancer

Denmark
TenNor Therapeutics (Suzhou) Limited

Completed

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of TNP-2198 Capsules in Asymptomatic Participants With Helicobacter Pylori Infection

Helicobacter Pylori Infection

China
Dong-A ST Co., Ltd.

Not yet recruiting

Bioequivalence Study Between "DA-5215 Tab" and "DA-5215-R Tab"

Healthy

Korea, Republic of
Tonix Pharmaceuticals, Inc.
Premier Research Group plc

Active, not recruiting

Assessment of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 Peptide Antigens (COVID-19 DTH)

Detection of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 in Individuals Exposed to SARS-CoV-2

United States
Chong Kun Dang Pharmaceutical

Completed

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388(2) in Healthy Subjects

Chronic Hepatitis b

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of DA-2803 in Healthy Subjects

Hepatitis B

Korea, Republic of
Taiwan Sunpan Biotechnology Development Co., Ltd.
Virginia Contract Research Organization Co., Ltd.

Completed

To Determine the MTD and to Evaluate the Safety, Efficacy and PK Profiles of TSB-9-W1 in Pre-treated Patients With mCRC. (TSB-9-W1)

Metastatic Colorectal Cancer

Taiwan
Dong-A ST Co., Ltd.

Completed

Bioequivalence Study Between "DA-5209 Tab" and "Lixiana Tab"

Healthy

Korea, Republic of
Chong Kun Dang Pharmaceutical

Unknown

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388 in Healthy Subjects

Chronic Hepatitis b

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers

Chronic Renal Failure

Korea, Republic of
Hanlim Pharm. Co., Ltd.

Completed

Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivikar Tab. 5/40 mg in Healthy Adult Male Subjects

Healthy Male Subjects

Korea, Republic of
Biocad

Recruiting

Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B (SAFRAN)

Hemophilia B

Russian Federation
Tabba Heart Institute
InnoTherapy Inc

Recruiting

Low Dose Heparin Factorial Trial

Radial Artery Occlusion

Pakistan
Santa Casa Medical School

Unknown

TNS for Treating Nicotine Craving (TNS-nicotine)

Nicotine Craving

Brazil
Tonix Pharmaceuticals, Inc.

Completed

Phase 1 Single Ascending Dose Safety Study of TNX-201 Capsules in Healthy Volunteers

Healthy

Search clinical trials for: TNB-383B

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations